Triclabendazole for the treatment of human fascioliasis and the threat of treatment failures.

: The only drug effective against the infection caused by Fasciola hepatica or F. gigantica is triclabendazole (TCBZ), recommended by the WHO and recently approved by the FDA. Here, we describe the...